Cargando…

Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach

AIMS: COVID-19 has currently emerged as the major global pandemic affecting the lives of people across the globe. It broke out from Wuhan Province of China, first reported to WHO on 31(st) December 2019 as “Pneumonia of unknown cause”. Over time more people were infected with this virus, and the onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waidha, Kamran, Saxena, Anjali, Kumar, Prashant, Sharma, Sunil, Ray, Devalina, Saha, Biswajit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017494/ https://www.ncbi.nlm.nih.gov/pubmed/33824915 http://dx.doi.org/10.1016/j.heliyon.2021.e06657

Ejemplares similares

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

In Silico Design and SAR Study of Dibenzyl Trisulfide Analogues for Improved CYP1A1 Inhibition
por: Clarke, Nishani, et al.
Publicado: (2022)

Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study
por: Singh, Atul Kumar, et al.
Publicado: (2021)

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach
por: Singh, Swati, et al.
Publicado: (2022)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

In silico design and evaluation of novel 5-fluorouracil analogues as potential anticancer agents
por: Chowdhury, Surid Mohammad, et al.
Publicado: (2020)

Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2
por: Juang, Yu-Pu, et al.
Publicado: (2022)

Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
por: Nutho, Bodee, et al.
Publicado: (2022)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions – An in-silico study
por: Seethy, Ashikh A., et al.
Publicado: (2021)

In-silico design of a potential inhibitor of SARS-CoV-2 S protein
por: Jaiswal, Grijesh, et al.
Publicado: (2020)

Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique
por: Ghosh, Nimisha, et al.
Publicado: (2022)

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
por: Sohail, Muhammad Saqib, et al.
Publicado: (2021)

In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2
por: Trezza, Alfonso, et al.
Publicado: (2022)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

In Vitro and In Vivo Therapeutic Potential of 6,6′-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2
por: Weiss, Shay, et al.
Publicado: (2023)

Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2021)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

In silico designing of a new cysteine analogue of hirudin variant 3 for site specific PEGylation
por: Sajjadi, Seyed Mehdi, et al.
Publicado: (2017)

Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021)

In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
por: Behloul, Nouredine, et al.
Publicado: (2021)

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022)

Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
por: Di Sarno, Veronica, et al.
Publicado: (2021)

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library
por: Liu, Nanxin, et al.
Publicado: (2023)

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
por: Ferdous, Nadim, et al.
Publicado: (2021)

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
por: Chien, Minchen, et al.
Publicado: (2020)

Enhanced Remdesivir Analogues to Target SARS-CoV-2
por: Majima, Ryuichi, et al.
Publicado: (2023)

In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
por: Masoomi Nomandan, Seyedeh Zeinab, et al.
Publicado: (2022)

Synthetic Methods for the Preparation of Conformationally Restricted Analogues of Nicotine
por: Panda, Biswajit, et al.
Publicado: (2021)

In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome
por: Alhatlani, Bader Y
Publicado: (2020)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
por: Zeyaullah, Md., et al.
Publicado: (2023)

In silico approach for identifying natural lead molecules against SARS-COV-2
por: Gupta, Shiv Shankar, et al.
Publicado: (2021)

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
por: Daikopoulou, Vasiliki, et al.
Publicado: (2021)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
por: Emami, Leila, et al.
Publicado: (2021)

Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach
por: Roy, Sawrab, et al.
Publicado: (2021)

Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors
por: Kumar, Sunil, et al.
Publicado: (2013)

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)
por: Wang, Ruyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_91l3872oeatssnhsp0vqi7s341